Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 2, 2003, Pages 229-237

  Henderson, Leigh A ^a   Vlahov, David ^b   Celentano, David D ^c   Strathdee, Steffanie A ^c  

^a Synectics for Mgmt Decisions Inc   (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIOR; COMMUNITY DYNAMICS; CONTROLLED STUDY; DEMOGRAPHY; DRUG DEPENDENCE; DRUG USE; DRUG WITHDRAWAL; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERVIEW; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; NEEDLE; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL EVOLUTION; UNITED STATES; VIRUS DETECTION;

EID: 0037321436     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200302010-00017     Document Type: Article

References (59)

1. Paone D, Des Jarlais DC, Gangloff R, et al. Syringe exchange: HIV prevention, key findings, and future directions. Int J Addict 1995; 30:1647-83.
2. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Soc Sci Med 2000;51:1771-82.
3. Paone D, Clark J, Shi Q, et al. Syringe exchange in the United States, 1996: a national profile. Am J Public Health 1999;89:43-6.
4. Lurie P, Reingold AL, Bowser B, et al. The public health impact of needle exchange programs in the United States and abroad. Summary, conclusions and recommendations. San Francisco: Berkeley Institute for Health Policy Studies, School of Public Health, University of California, 1993.
5. Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 2001;34:180-7.
6. Valenciano M, Emmanuelli J, Lert F. Unsafe injecting practices among attendees of syringe exchange programmes in France. Addiction 2001;96:597-606.
7. National Institutes of Health/National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA 1998;280: 1936-43.
8. Normand J, Vlahov D, Moses LE. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press, 1995.
9. Marx MA, Crape B, Brookmeyer RS, et al. Trends in crime and the introduction of a needle exchange program. Am J Public Health 2000;90:1933-6.
10. Doherty MC, Junge B, Rathouz P, et al. The effect of a needle exchange program on numbers of discarded needles: a 2-year follow-up. Am J Public Health 2000;90:936-9.
11. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle- exchange programmes for prevention of HIV infection. Lancet 1997;349:1797-800.
12. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996;348:987-91.
13. Kaplan EH, Heimer R. HIV incidence among needle exchange participants: estimates from syringe tracking and testing data. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:182-9.
14. van Ameijden EJ, van den Hoek AR, Coutinho RA. Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. Am J Public Health 1994;84:275-81.
15. Hagan H, Des Jarlais DC, Purchase D, et al. An interview study of participants in the Tacoma, Washington, syringe exchange. Addiction 1993;88:1691-7.
16. Vlahov D, Junge B, Brookmeyer R, et al. Reductions in high-risk drug use behaviors among participants in the Baltimore Needle Exchange Program. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:400-6.
17. Watters JK, Estilo MJ, Clark GL, et al. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 1994;271:115-20.
18. Vertefeuille J, Marx MA, Tun W, et al. Decline in self-reported high risk injection-related behaviors among HIV seropositive participants in the Baltimore Needle Exchange Program. AIDS Behav 2000;4:381-7.
19. Stimson GV. AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic. Soc Sci Med 1995;41:699-716.
20. Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995;274:1226-31.
21. Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment? J Subst Abuse Treat 1998;15:183-91.
22. Strathdee SA, Celentano DD, Shah N, et al. Needle-exchange attendance and health care utilization promote entry into detoxification. J Urban Health 1999;76:448-60.
23. Shah NG, Celentano DD, Vlahov D, et al. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 2000;14:2035-43.
24. Hagan H, McGough JP, Thiede H, et al. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat 2000;19:247-52.
25. Substance Abuse and Mental Health Services Administration. Uniform facility data set (UFDS): 1998. Drug and Alcohol Services Information System Series: S-10. DHHS Publication (SMA) 003463. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2000.
26. Liebman J, Knezek LD, Coughey K, et al. Injection drug users, drug treatment, and HIV risk behavior. In Brown BS, Beschner GM, eds. Handbook on risk of AIDS: injection drug users and sexual partners. Westport, CT: Greenwood Press, 1993:355-73.
27. Jackson JF, Rotkiewicz LG, Quinones MA, et al. A coupon program: drug treatment and AIDS education. Int J Addict 1989;24: 1035-51.
28. Kreek MJ. Rationale for maintenance pharmacotherapy of opiate dependence. Research Publications: Association for Research in Nervous and Mental Disease 1992;70:205-30.
29. National Institute on Drug Abuse. Methadone maintenance treatment: translating research into policy. Washington, DC: NIDA, 1995.
30. Office of National Drug Control Policy. Treatment protocol effectiveness. A white paper of the Office of National Drug Control Policy. J Subst Abuse Treat 1996;13:295-319.
31. McLellan AT, O'Brien CP, Metzger D, et al. How effective is substance abuse treatment - compared to what? Research Publications: Association for Research in Nervous and Mental Disease 1992;70:231-52.
32. White JM, Dyer KR, Ali RL, et al. Injecting behavior and risky needle use amongst methadone maintenance clients. Drug Alcohol Depend 1994;34:113-9.
33. Caplehorn JRM, Ross MW. Methadone maintenance and the likelihood of risky needle-sharing. Int J Addict 1995;30:685-98.
34. Wells EA, Calsyn DA, Clark LL, et al. Retention in methadone maintenance is associated with reductions in different HIV risk behaviors for women and men. Am J Drug Alcohol Abuse 1996; 22:509-21.
35. MacGowan RJ, Brackbill RM, Rugg DL, et al. Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New England. AIDS 1997;11:229-35.
36. Bruneau J, Lamothe F, Franco E, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol 1997;146:994-1002.
37. Schechter MT, Strathdee SA, Cornelisse PG, et al. Do needle exchange programmes increase the spread of HIV among injection drug users? An investigation of the Vancouver outbreak. AIDS 1999;13:F45-51.
38. DiClemente CC, Prochaska JO. Self-change and therapy change of smoking behavior: a comparison of processes of change in cessation and maintenance. Addict Behav 1982;7:133-42.
39. Prochaska JO, DiClemente CC. Stages and processes of selfchange of smoking: toward an integrative model of change. J Consult Clin Psychol 1983;51:390-5.
40. Prochaska JO, Velicer WF, Rossi JS, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol 1994; 13:39-46.
41. Belding MA, Iguchi MY, Lamb RJ, et al. Stages and processes of change among polydrug users in methadone maintenance treatment. Drug Alcohol Depend 1995;39:45-53.
42. Belding MA, Iguchi MY, Lamb RJ. Stages and processes of change as predictors of drug use among methadone maintenance patients. Exp Clin Psychopharmacol 1997;5:65-73.
43. De Leon G, Melnick G, Kressel D, et al. Circumstances, motivation, readiness, and suitability (the CMRS scales): predicting retention in therapeutic community treatment. Am J Drug Alcohol Abuse 1994;20:495-515.
44. Melnick G, De Leon G, Hawke J, et al. Motivation and readiness for therapeutic community treatment among adolescents and adult substance abusers. Am J Drug Alcohol Abuse 1997;23:485-506.
45. Joe GW, Simpson DD, Broome KM. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 1998;93:1177-90.
46. Booth RE, Kwiatkowski C, Iguchi MY, et al. Facilitating treatment entry among out-of-treatment injection drug users. Public Health Rep 1998;113(Suppl 1):116-28.
47. Bluthenthal RN, Longshore D, Stein M, et al. Factors associated with readiness to change drug use among needle exchange users. Drug Alcohol Depend 2001;62:225-30.
48. Vlahov D, Anthony JC, Muñoz A, et al. The ALIVE study: a longitudinal study of HIV-1 infection in intravenous drug users: a description of methods. J Drug Issues 1991;21:759-76.
49. Anthony JC, Vlahov D, Celentano DC, et al. Self-report interview data for a study of HIV-1 infection among intravenous drug users: description of methods and preliminary evidence on validity. J Drug Issues 1991;21:739-57.
50. Simpson DD, Chatman LR. TCU/DATAR forms manual: improving drug abuse treatment, assessment, and research (DATAR) project. Fort Worth, TX: Institute of Behavioral Research, 1995.
51. Knight K, Holcom M, Simpson DD. TCU psychosocial functioning and motivation scales: manual on psychometric properties. Fort Worth, TX: Institute of Behavioral Research, 1994.
52. Henderson LA. Readiness to stop drug use: a stage-of-change model in a population of current and former injection drug users. University Microfilm International, 2000.
53. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system. Cary, NC: SAS Institute, 1995.
54. Sibthorpe B, Fleming D, Tesselaar H, et al. The response of injection drug users to free treatment on demand: implications for HIV control. Am J Drug Alcohol Abuse 1996;22:203-13.
55. Schütz CG, Rapiti E, Vlahov D, et al. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend 1994;36: 129-38.
56. Zule WA, Desmond DP, Vogtsberger KN. Injecting drug users who want treatment. Am J Drug Alcohol Abuse 1997;23:507-22.
57. Brooner R, Kidorf M, King V, et al. Drug abuse treatment success among needle exchange participants. Public Health Rep 1998;113(Suppl 1):129-39.
58. Langendam MW, van Brussel GH, Coutinho RA, et al. Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study. Addiction 2000;95:591-600.
59. Nelson KE, Vlahov D, Solomon L, et al. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, MD. Arch Intern Med 1995;155: 1305-11.